TransMedics Shares Halted Ahead of FDA Meeting
July 14 2021 - 07:41AM
Dow Jones News
By Matt Grossman
TransMedics Group Inc. shares have had trading halted on the
Nasdaq ahead of a regulatory meeting that will review one of the
company's products.
The Food and Drug Administration's panel for gastroenterology
and urology devices will meet at 9 a.m. ET to discuss TransMedic's
liver system, a portable device designed to preserve a donated
liver prior to transplant.
Shares of Andover, Mass.-based TransMedics fell by 5.3% on
Tuesday, to close at $31.69.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
July 14, 2021 07:34 ET (11:34 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
TransMedics (NASDAQ:TMDX)
Historical Stock Chart
From Feb 2024 to Mar 2024
TransMedics (NASDAQ:TMDX)
Historical Stock Chart
From Mar 2023 to Mar 2024